|  Help  |  About  |  Contact Us

Publication : Phenotypic expression of the mouse lymphocyte surface alloantigens.

First Author  Tada N Year  1989
Journal  Mouse News Lett Volume  84
Pages  59-71 Mgi Jnum  J:14246
Mgi Id  MGI:62418 Citation  Tada N, et al. (1989) Phenotypic expression of the mouse lymphocyte surface alloantigens. Mouse News Lett 84:59-71
abstractText  PHENOTYPIC EXPRESSION OF THE MOUSE LYMPHOCYTE SURFACE ALLOANTIGENS Nobuhiko Tada, Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa, Japan; Shoji Kimura, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021 USA; Shuji Ikegami, Division of Immunogenetics, Meiji Institute of Health Science, 540 Naruda, Odawara, Japan. Comments written on paper: chr 1: Fcgr2, Sell, Ly33. chr 2: B2m. chr 4: Cd72, Ly31. chr 12: Ly18. chr 13: Ly28. chr 15: Ly6. chr 19: Cd5, Ly10. Comment: The RI strain distributions presented here are a compilation from SDPs reported in the original papers. Table 1. Strain distribution of Ly-6A alloantigen* LY-6A.1 (negative): A/HeJ, Au/SsJ, BALB/cByJ, C3H/An, C3Hf/Bi, C3H/Fg, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, CBA/CaJ, CBA/HN, CBA/H-T6J, CBA/J, CE/J, HRS/J, NZB/B1NJ, NZB/B1SCr, NZB/Minnesota, NZW/LacJ, 020/A, RIIIS/J, SEA/GnJ, SEC/IreJ, ST/bJ, STS/A, CALB/Rk, CAST/Ei, IS/CamEi, Mus caroli, Mus poschiavinus, Mus spretus, PERA/Rk, Peromyscus maniculatus, Peru-Atteck/Ei, SF/CamEi, SK/CamEi, BXH-3, 7, 8, 9, 19; CXB-G, H, J, N, O, P; NX129-5, 7, 12; OXA-3, 4, 7, 10, 12, 13. LY-6A.2 (positive): AKR/FuRdA, AKR/J, BDP/J, BUB/BnJ, C57BL/6ByJ, C57BL/KsJ, C57BL/10J, B10.S, C57BR/cdJ, C57L/J, C58/J, DBA/1J, DBA/2J, GR/A, HSFS/N, I/LnJ, I/St, LG/J, LP/J, LT/Sv, MA/MyJ, P/J, PL/J, RF/J, SJL/J, SM/J, SWR/J, 129/J, 129/SvJ, C3H.B6-Ly-6b(90NS), MOLC/Rk, MOLD/Rk, MOLE/Rk, MOLF/Ei, BXH-2, 4, 6, 10, 11, 12, 14; CXB-D, E, I, K, L, Q, R; NX129-1, 2, 10; OXA-1, 2, 5, 6, 8, 11. References: Immunogenetics 11: 373-381, 1980; 20: 47-56, 1984), *In the parentheses, negative or positive indicates that the phenotypic expression of each mouse strain was determined by the absence or presence, respectively, of the reaction in the cytotoxicity assay. Table 2. Ly-1 and Ly-10 phenotypes of various mouse strains Ly-l.1, Ly-10.1 (positive): C3Hf/Bi, C3H/Fg, CBA/CaJ, CBA/H, CBA/HN, CBA/J, DBA/1J, DBA/2J, C57BL/6.C3H/An-Ly-1a/Boy, CALB/Rk, SF/CamEi, SK/CamEi, AKXD-1, 2, 3, 8, 10, 14, 15, 22, 25, 28; BXD-6, 8, 13, 20, 23, 24, 31. Ly-1.2, Ly-10.1 (positive): C57BR/cdJ, C57L/J, CAST/Ei, IS/CamEi, MOLC/Rk, MOLD/Rk, MOLE/Rk, MOLF/Ei, Mus poschiavinus, AKXD-16, AKXL-8, 13, 16, 17, 19, 21A, 38; BXD-1, LXPL-6. Ly-1.1, Ly-10.2 (negative): C3H/An, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, MA/MyJ, AKXD-12, BXD-20. Ly-1.2, Ly-10.2 (negative): A/HeJ, AKR/FuRdA, AKR/J, AU/SsJ, BALB/cByJ, BDP/J, BUB/BnJ, C57BL/6ByJ, C57BL/10J, C58/J, CE/J, GR/A, Hollander, HRS/J, HSFS/N, I/LnJ, I/St, JA4/A.Mph-1, LG/J, LP/J, LT/Sv, NZB/B1NJ, NZW/LacJ, 020/A, P/J, PL/J, RF/J, RIIIS/J, SEA/GnJ, SEC/1ReJ, SJL/J, SM/J, ST/bJ, STS/A, SWR/J, 129/J, 129/SvJ, Mus spretus, PERA/Rk, Peru-Atteck/Ei, AKXD-6, 7, 9, 11, 13, 17, 18, 20, 21, 23, 24, 26, 27; AKXL-5, 6, 7, 9, 14, 24, 25, 28, 29, 37; BXD-2, 5, 9, 11, 12, 14, 15, 16, 18, 19, 21, 22, 25, 28, 29, 32; LXPL-1, 4. (References: Immunogenetics l0: 363-372, 1980; 17: 211-214, 1983) Table 3. Allotype of mouse beta-2-microglobulin B allele (positive): C57BL/6ByJ, C57BL/KsJ, C57BL/10J, B10.S, C57BR/cdJ, C57L/J, LG/J, MOLC/Rk, MOLD/Rk, MOLE/Rk, MOLF/Ei, B10.CE (30NX)/Sn, B10.KR-H-3d/Sn, B10.KR-H-13?A/Sn, B10.LP-H-13bAw/Sn, B10-paH-3eat/Sn, AKXL-5, 6, 7, 9, 13, 14, 16, 19, 21A, 29, 38; BXD-1, 2, 5, 6, 9, 13, 14, 22, 25, 31; BXH-2, 3, 4, 6, 7, 9, 11, 19; BXJ-2; CXB-E, G, I, J, K, Q, R; LXPL-1, 6; SWXL-7, 12, 14, 15, 17. Non b allele (negative): A/HeJ, AKR/J, AU/SsJ, BALB/cByJ, BDP/J, BUB/BnJ, C58/J, C3H/An, C3Hf/Bi, C3H/Fg, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, CBA/CaJ, CBA/H, CBA/HN, CBA/J, CE/J, DBA/1J, DBA/2J, GR/A, HRS/J, HSFS/N, I/LnJ, I/St, JA4/A.Mph-1, LP/J, LT/Sv, MA/MyJ, NZB/B1NJ, NZW/LacJ, 020/A, P/J, PL/J, RF/J, RIIIS/J, SEA/GnJ, SEC/1ReJ, SJL/J, SM/J, ST/bJ, STS/A, SWR/J, 129/J, 129/Sv, CALB/Rk, CAST/Ei, IS/CamEi, Mus caroli, Mus poschiavinus, Mus spretus, PERA/Rk, Peromyscus maniculatus, Peru-Atteck/Ei, SF/CamEi, SK/CamEi, B10.C (28NX)/Sn, B10.C-H-3c/Sn, B10.LP/Sn, B10.LP-H-3b/Sn, AKXL-8, 12, 17, 24, 25, 28, 37; BXD-8, 11, 12, 15, 16, 18, 19, 20, 21, 23, 24, 27, 28, 29, 30, 32; BXH-8, 10, 12, 14; BXJ-1; CXB-D, H, L, N, O, P; LXPL-4; SWXL-4, 16. References: Immunogenetics 11: 373-381, 1980; 14: 445-447, 1981; 15: 605-608, 1982; 18: 173-175, 1983; Immuno. Rev. 69: 99-126, 1982). Table 4. Strain distribution of Ly-17 alloantigen Ly-17.1 (negative): A/HeJ, AU/SsJ, BDP/J, BUB/BnJ, C3H/An, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3H/HeB/FeJ, CBA/CaJ, CBA/H, CBA/HN, CBA/H- T6J, CE/J, GR/A, HSFS/N, LG/J, LP/J, NZB/B1NJ, NZW/LacJ, O20/A, P/J, PL/J, RF/J, RIIIS/J, SEA/GnJ, SJL/J, SM/J, STb/J, STS/A, SWR/J, 129/J, 129/SvJ, IS/CamEi, Mus caroli, Mus poschiavinus, Mus spretus, Peromyscus maniculatus, Peru-Atteck/Ei, SF/CamEi, SK/CamEi, CXS-1, 4, 7, 8, 9, 11, 13, 14; BXH-6, 9, 12, 14; BXJ-1; LXPL-1; OXA-1, 3, 9, 11, 12, 13, 14; SWXL-4, 7, 14, 15, 16. Ly-17.2 (positive): AKR/FuRdA, AKR/J, BALB/cByJ, C57BL/KsJ, C57BL/6ByJ, C57BL/10J, B10.S, C57BR/cdJ, C57L/J, C58/J, C3Hf/Bi, C3H/Fg, CBA/J, DBA/1J, DBA/2J, HRS/J, I/LnJ, I/St, JA4/A.Mph-1, LT/Sv, MA/MyJ, SEC/1ReJ, CAST/Ei, MOLF/Ei, CXS-2, 3, 5, 6, 10, 12; BXH-2, 3, 4, 7, 8, 10, 11, 19; BXJ-2; LXPL-4, 6; OXA-2, 4, 5, 6, 7, 8, 10; SWXL-12, 17. (Reference: Immunogenetics 14: 3-14, 198) Table 5. Strain distribution of Ly-18 alloantigen* Ly-18.1 (negative): AKR/FuRdA, A/HeJ, AKR/J, A.SW/SnJ, BALB/cByJ, BDP/J, BUB/BnJ, B10.AM, B10.S, B10.S(12R), B10.S(24R), C3H/An, C3Hf/Bi, C3H/Fg, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, CBA/CaJ, CBA/H, CBA/HN, CBA/J, JA4/A.Mph-l, LP/J, P/J, PL/J, RF/J, RIIIS/J, SEA/GnJ, SEC/1ReJ, 129J, 129/SvJ, CAST/Ei, IS/CamEi, MOLC/Rk, MOLD/Rk, MOLE/Rk, MOLF/Ei, Mus caroli, Mus poschiavinus, Mus spretus, PERA/Rk, Peromyscus maniculatus, Peru-Atteck/Ei, SF/CamEi, SK/CamEi, AKXD-3, 7, 9, 12, 13, 14, 17, 20, 21, 22, 23, 24, 27, 28; SWR/ J, AKXL-5, 6, 9, 12, 14, 16, 17, 24, 25, 29, 38; BXH-7, 9, 11, 12, 14, 19; CXB-E, G, H, I, K, L, P; CXS-2, 4, 7, 9, 14; LXPL-1; NX129-1, 7, 10, 12; OXA-1, 5, 9, 13. Ly-18.2 (positive): AU-SsJ, C57BL/6ByJ, C57BL/10J, C57BL/10SnJ, B10.A, B10.D2, B10.M, B10.BR, B10.P, B10.BSVS, B10.A(1R), B10.A(2R), B10.A(3R), B10.A(4R), B10.A(5R), B10.T(6R), B10.S(7R), B10.S(8R), B10.S(9R), B10.P(10R), B10.M(11R), B10.F(13R), B10.F(14R), B10.A(15R), B10.S(2R), B10.S(23R), B10.BSVS(25R), B10.S(26R), B10.S(30R), C57BR/cdJ, C57L/J, C58/J, CE/J, DBA/1J, DBA/2J, GR/A, HRS/J, HSFS/N, I/LnJ, I/St, LG/J, LT/Sv, MA-MyJ, NZB/B1NJ, NZW/LacJ, 020/A, SJL/J, SM/J, ST/bJ, STS/A, SWR/J, CALB/Rk, AKXD-1, 2, 6, 8, 10, 11, 15, 16, 18, 25, 26; AKXL-7, 8, 13, 19, 21A, 28, 37; BXH-2, 3, 4, 6, 8, 10; CXB-D, J, N, O, Q, R; CXS-1, 3, 5, 6, 8, 10, 11, 12, 13; LXPL-4, 6; NX129-2, 5; OXA-2, 3, 4, 6, 7, 8, 10, 11, 12, 14. (Reference: Immunogenetics 13: 1981), *B10-related congenic mice were typed by Dr. J. Stimpfling. Table 6. Strain distribution of Ly-19 alloantigen Ly-19.1 (negative): AKR/FuRdA, AKR/J, BDP/J, CE/J, GR/A, LG/J, P/J, RF/J, SEA/GnJ, SJL/J, B6.CE-Lyb-2c/Boy, Peromyscus maniculatus, AKXD-1, 2, 8, 9, 10, 11, 12, 13, 16, 20, 21, 24, 26, 28; AKXL-6, 7, 8, 12, 13, 16, 17, 21A, 24, 25, 28, 29, 38; BXJ-2; OXA-1, 3, 5, 6, 7, 9, 11. Ly-19.2 (positive): A/HeJ, AU/SsJ, BALB/cByJ, BUB/BnJ, C57BL/KsJ, C57BL/6ByJ, C57BL/10J, B10.S, C57BR/cdJ, C57L/J, C58/J, C3H/An, C3Hf/Bi, C3H/Fg, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, CBA/CaJ, CBA/HN, CBA/H-T6J, CBA/J, DBA/1J, DBA/2J, HRS/J, HSFS/N, I/LnJ, I/St, JA4/A.Mph-1, LT/Sv, LP/J, MA/MyJ, NZB/B1NJ, NZW/LacJ, 020/A, PL/J, RBF/DnJ, RIIIS/J, SEC/1ReJ, SM/J, T/bJ, STS/A, SWR/J, WB/ReJ, WC/ReJ, CALB/Rk, CAST/Ei, IS/CamEi, MOLF/Ei, Mus caroli, Mus poschiavinus, Mus spretus, PERA/Rk, Peru-Atteck/Ei, SF/CamEi, SK/CamEi, AKXD-3, 6, 7, 14, 15, 17, 18, 22, 23, 25, 27; AKXL-5, 9, 14, 19, 37; BXJ-1; OXA-2, 4, 8, 10, 12, 13, 14. (Reference: Immunogenetics 13: 539-546, 1981) Table 7. Strain distribution of Ly-22 alloantigen LY-22.1 (negative): AU/SsJ, BDP/J, BUB/BnJ, DBA/1J, DBA/2J, GR/A, I/LnJ, I/St, NZB/B1NJ, NZW/LacJ, P/J, RF/J, RIIIS/J, SEA/GnJ, SJL/J, SM/J, ST/bJ, STS/A, SWR/J, CAST/Ei, MOLC/Rk, MOLD/Rk, MOLE/Rk, MOLF/Ei, Mus caroli, Mus poschiavinus, Mus spretus, Peromyscus maniculatus, AKXD-2, 6, 7, 10, 12, 16, 17, 20, 25; BXD-5, 9, 11, 13, 15, 22, 23, 24, 25, 27, 28, 29, 30, 32; BXJ-1; CXS-1, 4, 6, 7, 8, 9, 11, 13, 14; NX129-1, 5, 10, 12; SWXL-7, 14, 15, 16. Ly-22.2 (positive): A/HeJ, AKR/J, BALB/cByJ, C57BL/KsJ, C57BL/6ByJ, C57BL/10J, B10.S, C57BR/cdJ, C57L/Akvp, C57L/J, C58/J, C3H/An, C3Hf/Bi, C3H/Fg, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, CBA/CaJ, CBA/HN, CBA/J, CE/J, HRS/J, LG/J, LP/J, LT/Sv, MA/MyJ, 020/A, PL/J, SEC/1ReJ, 129/J, 129/SvJ, IS/CamEi, PERA/Rk, Peru-Atteck/Ei, SK/CamEi, AKXD-1, 3, 8, 9, 11, 13, 14, 15, 18, 21, 22, 23, 24, 26, 27, 28; BXD-1, 2, 6, 8, 12, 14, 16, 18, 19, 20, 21, 31; BXJ-2; CXS-2, 3, 5, 10, 12; NX129-2; SWXL-4, 12, 17. (References: Hybridoma 2: 29-38, 1983; Immunogenetics 26: 315-316, 1987) Table 8. Strain distribution of Ly-28 alloantigen Ly-28.1 (negative): AKR/FuRdA, AKR/J, AKR/N, RF/J, RIIIS/J, AKXD-11, 16, 23; AKXL-6, 9, 16, 17, 24, 38; OXA-2, 3, 9, 10, 11, 14. Ly-28.2 (positive): A/J, A/HeJ, A/WySnJ, BALB/cByJ, BALB/cJ, BDP/J, BUB/BnJ, C57BL/ksJ, C57BL/6J, C57BL/6ByJ, C57BL/10J, C57BL/10SnJ, B10.A, B10.BR, C57BR/cdJ, C57L/J, C58/J, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, CBA/CaH-T6J, CBA/CaJ, CBA/J, CBA/NJ, CE/J, DBA/1J, DBA/1LacJ, DBA/2J, I/LnJ, LP/J, LG/J, MA/MyJ, NZB/B1NJ, NZW/LacJ, 020/A, P/J, PL/J, RBF/DnJ, SEA/GnJ, SEC/1ReJ, SJL/J, SM/J, ST/bJ, STS/A, SWR/J, WB/ReJ, WC/ReJ, 129/J, 129/ReJ, 129/SvJ, A.AL-Thy-1a/Boy, B10.NRH-Thy-1a/Nrs, CALB/Rk, CAST/Ei, IS/CamEi, MOLC/Rk, MOLD/Rk, MOLE/Rk, MOLF/Ei, Mus caroli, Mus poschiavinus, Mus spretus, PERA/Rk, Peromyscus maniculatus, Peru-Attech/Ei, SF/CamEi, SK/CamEi; AKXD-1, 8, 9, 10, 13, 14, 21, 25, 27, 28; AKXL-7, 8, 13, 14, 21, 28, 29, 37; OXA-1, 4, 5, 6, 7, 8, 12, 13. (Reference: Immunogenetics 24: 275-277, 1986) Table 9. Strain distribution of Ly-31 alloantigen Ly-31.1 (positive): A/Boy, A/HeJ, A/WySn, A.CA/SnJ, AKR/Boy, AKR/FuRdA, AKR/J, AU/SsJ, BALB/cBoy, BALB/cByJ, BALB-Dh, BUB/BnJ, BUB/BnJ, C3H/An, C3H/Ân, C3Hf/Bi, C3H/Fg, C3H/ HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, CBA/CaJ, CBA/HN, CBA/J, CE/J, DBA/2DeJ, DBA/2J, GR/A, Hollander, HRS/J, I/LnJ, I/St, LG/J, LT/SvJ, MA/MyJ, NZB/BINJ, NZW/LacJ, 020/A, PL/J, RF/J, SEC/1ReJ, SJL/J, ST/bJ, STS/A, SWR/J, AKXL-6, 7, 9, 12, 14, 17, 19, 29, 38; BXD-1, 8, 12, 13, 14, 15, 16, 18, 21, 23, 28, 30, 32; BXH-6, 7, 9, 10, 11, 19; CXB-G, I, L, N, P; LXPL-4, 6; NX129-2, 5, 10; SWXL-12, 15, 17. Ly-31.2 (negative): BDP/J, C57BL/6Boy, C57BL/6ByJ, C57BL/KsJ, C57BL/10J, C57BL/10SnJ, B10.S, C57BR/cdJ, C57L/J, C58/J, DBA/1J, DBA/1LacJ, P/J, RIIIS/J, SEA/GnJ, SM/J, WB/Re, WC/Re, 129/Boy, 129/J, 129/SvJ, AKR.B6-Fv-1b, AKR.B6-Fv-1b; B6-GIX(-), AKR.B6-H-2b; B6-Fv-1b, B6.AKR-Fv-1n, B6.129-GIX(+), C57BL/6-GIX(+)M, C57BR-GIX(+)M, 129.B6-GIX(-), 129.B6-GIX(-); BALB-Fv-1b, CAST/Ei, Mus spretus, Peru-Atteck/Ei, AKXL-5, 8, 13, 16, 21, 24, 25, 28, 37; BXD-2, 5, 6, 9, 11, 19, 22, 24, 25, 27, 29, 31; BXH-2, 3, 4, 8, 12, 14; CXB-D, E, H, J, K, O, Q, R; LXPL-1; NX129-1, 12; SWXL-4, 7, 14, 16. (Reference: Immunogenetics 20: 589-592, 1984) Table 10. Strain distribution of Ly-32 alloantigen Ly-32.1 (negative): AKR/J, AKR/FuRdA, AKR/N, BDP/J, C57BR/cdJ, C57L/J, C58/J, CBA/J, CE/J, DBA/1J, DBA/1LacJ, DBA/2J, I/LnJ, LG/J, P/J, RBF/DnJ, RF/J, SEA/GnJ, SJL/J, SM/J, ST/bJ, STS/A, SWR/J, B6.I-Lyb-2a/Boy, CALB/Rk, CAST/Ei, MOLC/Rk, MOLD/Rk, MOLE/Rk, MOLF/Ei, Mus caroli, Mus poschiavinus, Mus spretus, Peromyscus maniculatus, BXD-1, 13, 21, 22, 24, 25, 30; CXS-2, 5, 10, 11, 12, 14; OXA-3, 5, 6, 7, 9, 11. Ly-32.2 (positive): A/J, A/HeJ, A/WySnJ, BALB/cJ, BALB/cByJ, BUB/BnJ, C57BL/KsJ, C57BL/6J, C57BL/6ByJ, C57BL/10J, C57BL/10SnJ, B10.A, B10.BR, B10.D2, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, CBA/CaH-T6J, CBA/CaJ, CBA/NJ, LP/J, MA/MyJ, NZB/B1NJ, NZW/LacJ, 020/A, PL/J, RIIIS/J, SEC/1ReJ, WB/ReJ, WC/ReJ, 129/J, 129/ReJ, 129/SvJ, IS/CamEi, SF/CamEi, SK/CamEi, PERA/Rk, Peru-Atteck/Ei, BXD-2, 5, 6, 8, 9, 11, 12, 14, 15, 16, 18, 19, 23, 27, 28, 29, 31, 32; CXS-1, 3, 4, 6, 7, 8, 9, 13; OXA-1, 2, 4, 8, 10, 12, 13, 14. (Reference: Immunogenetics 25: 269-270, 1987) Table 11. Strain distribution of Ly-33 alloantigen Ly-33.1 (negative): GR/A, LIS/A, NZW/LacJ, RF/J, STS/A, Mus caroli, Mus poschiavinus, Peromyscus maniculatus, CXS-1, 2, 4, 7, 9, 13, 14. Ly-33.2 (positive): A/HeJ, A/Sn, A.CA/Sn, AKR/J, AU/SsJ, BALB/cByJ, BDP/J, BRVR, BUB/BnJ, C57BL/6ByJ, C57BL/10J, C57BL/KsJ, B10.S, C57BR/cdJ, C57L/J, C58/J, C3H/An, C3Hf/Bi, C3H/Fg, C3H/HeJ, C3H/HeSnJ, C3H/OuJ, C3HeB/FeJ, CBA/CaJ, CBA/H, CBA/HN, CBA/H-T6J, CBA/J, CE/J, DBA/1J, DBA/1LacJ, DBA/2J, HRS/J, I/LnJ, LG/J, LP/J, MA/MyJ, NZB/B1NJ, P/J, PL/J, RIIIS/J, SEA/GnJ, SEC/1ReJ, SJL/J, SM/J, ST/bJ, SWR/J, VM, 129/J, 129/SvJ, CALB/Rk, CAST/Ei, IS/CamEi, MOLC/Rk, MOLD/Rk, MOLE/Rk, MOLF/Ei, Mus spretus, PERA/Rk, Peru-Atteck/Ei, SF/CamEi, SK/CamEi, CXS-3, 5, 6, 8, 10, 11, 12. (Reference: Immunogenetics 26: 315-316, 1987) Table 12. Strain distribution of Ly-36 alloantigen Ly-36.1 (positive): MOLC/Rk, MOLD/Rk, MOLE/Rk, MOLF/Ei. Ly-36-2 (negative): A/HeJ, A/J, A/WySnJ, AKR/FuRdA, AKR/J, BALB/cByJ, BALB/cJ, BDP/J, BUB/BnJ, CBA/CaJ, CBA/NJ, CBA/CaH-T6J, CBA/J, C57BL/6ByJ, C57BL/6J, C57BL/10J, C57BL/10SnJ, C57BL/KsJ, C57BR/cdJ, C57L/J, C58/J, CE/J, C3HeB/FeJ, C3H/HeJ, C3H/OuJ, C3H/HeSnJ, DBA/1J, DBA/1LacJ, DBA/2J, DD/HeAf, GRS/A, I/LnJ, LG/J, LIS/A, LP/J, MA/MyJ, MAS/A, NZB/B1NJ, NZW/LacJ, 020/A, P/J, PL/J, PWD/PhA, PWK/PhA, RBF/DnJ, RF/J, RIIIS/J, SEA/GnJ, SEC/1ReJ, SJL/J, SM/J, ST/bJ, STS/A, SWR/J, TSI/A, TW1/A, TW18/A, TW32/A, 129/J, 129/ReJ, 129/SvJ, WB/ReJ, WC/ReJ, WLL/BrAf, CALB/Rk, CAST/Ei, IS/CamEi, Mus caroli, Mus poschiavinus, Mus spretus, PERA/Rk, Peromyscus maniculatus, Peru-Atteck/Ei, SF/CamEi, Sk/CamEi. (Reference: Immunogenetics 28: 50-52, 1988)
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Authors

11 Bio Entities

Trail: Publication

0 Expression